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basilar insufficiency or stroke based upon cerebrovascu-
lar anatomy.
CONCLUSION
Coverage of the left SCA origin usually does not lead to
left upper extremity ischemic symptoms and can be man-
aged expectantly. Although manipulation of guidewires
and deployment devices within the arch may place patients
at risk for embolic events, left SCA coverage appears to be
well tolerated in individuals with collateral perfusion to the
basilar system. Partial left SCA coverage may place the
patient at risk for the development of a type IA endoleak.
We would like to thank Laura Kissell, MD, and Dianne
L. Glover, RN, CVN, for their assistance in the acquisition
of data for this study.
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Dr Joseph Coselli (Houston, Tex). The authors should be
congratulated on a very fine presentation. This is going to be a very
important contribution providing additional baseline data regard-
ing left subclavian artery occlusion during thoracic stent grafting
with exclusion of thoracic aortic pathology. The mortality and
stroke rates, however, were rather notable, both being at about
11%. This is generally higher than what we would like to see in a
minimally invasive procedure although, admittedly, in your series
nine of your patients, 32%, had undergone emergency repairs.
We, in our work, have an expanding group of these debranch-
ing procedures where the total arch is replaced using zone 1 and
would concur with your findings that, as of yet, although compli-problem. As of yet, neurological complications, in our experience,
have not occurred. We, however, have carried out all of our
procedures at the same operative setting, with both the debranch-
ing and the endovascular exclusion carried out under the same
anesthetic. Intentional coverage of the left subclavian artery has
been demonstrated to be reasonable and safe in this setting. But,
do you believe that there is a difference in the incidence of
endoleaks, particularly type 2, when the left subclavian artery arises
off an aneurysmal portion of the aorta versus arising as a branch
from a normal aortic segment where the technique is really em-
ployed to extend and enhance the proximal landing zone?
In your manuscript, which you kindly provided in advance,
you don’t address the other two strokes, and I think themanuscript
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tion of the embolic strokes. For example, were they occurring in
the distribution of the left vertebral artery?
The manuscript also does not address the issue of paraplegia.
The vertebral artery branch of the left subclavian artery is, of
course, an inflow source to the anterior spinal artery. Could you
comment further on paraplegia as an entity, both for this particular
subset of patients as well as your broader experience regarding
coverage of the descending thoracic aorta?
I would appreciate your thoughts on the routine use of CSF
drainage. You mention that you use it in patients who either had
concomitant or prior abdominal aortic aneurysm replacement. You
have an overall experience I think which would be valuable to
comment on the routine CSF drainage.
Would you please comment on the need for the immediate
availability of cardiopulmonary bypass when using zone one?
Emergency cases seem to pose several problems that might
make ischemic complications more likely. Understandably, they
may not undergo sufficient evaluation of cerebral circulation be-
fore the procedure and may present with associated shock and
coexisting injuries making their neurological status difficult to
assess. Similarly, their early postoperative course may make neuro-
logical assessment challenging. Finally, ongoing global hypoperfu-
sion, as you had in one of your own patients due to organ failure
and other injuries, may exacerbate ischemic complications. Given
these concerns, should the left subclavian artery be routinely
revascularized during stent graft placement where you had these
conflicting issues?
Finally, do you have a concern about the long-term durability
of an unsupported ascending aorta for a proximal landing site, not
only in patients with significant connective tissue issues, such as
Marfan syndrome or Ehler-Danlos syndrome, but also in patients
with reduced aortic wall strength and integrity of lesser severity
such as those with bicuspid aortic valves, etc? You have recom-
mended that the patients undergo preprocedural studies to iden-
tify those at risk for vertebrobasilar insufficiency, yet the informa-
tion obtained, at least in your manuscript, was not actually used to
modify the procedures carried out. Would you comment, conse-
quently, on how strongly you recommend this process?
Dr Paul J. Riesenman. Thank you, Dr Coselli. To address
some of those issues, with respect to our three strokes, as I said in
the presentation, one patient did sustain his CVA as a consequence
of his intraoperative cardiac arrest, and it was a watershed pattern
seen on subsequent CT scan. An additional patient had a similar
pattern and appeared to be possibly from a hypotensive episode.
The other patient actually did not have any radiographic signs or
evidence of stroke but he did have clinical symptoms of it. All those
patients underwent MR evaluation, which showed that the stroke
was not a consequence of a loss of blood flow to the vertebrobasilar
territory, so these were not strokes within that territory. If they
were, we would conclude they were a consequence of coverage of
the left subclavian and cessation of blood flow to the left vertebral.
With respect to our paraplegia, we have not seen—yes, the left
vertebral can contribute to flow through the anterior spinal ar-tery—but we have not had any evidence of paraplegia in our overall
group, nor have we in this subgroup whatsoever.
With respect to routine CSF drainage, we typically only use
that in patients who have undergone previous abdominal aortic
aneurysm repair but not necessarily in patients who do not have
pathology below their diaphragm.
There were several other questions. I can’t remember them all
that you proposed to me.
Dr Mark Farber. Let me add to that. Dr Riesenman is a
third-year resident in our program and he has done a terrific job,
but to answer some of the issues that Dr Coselli brings up in terms
of the routine left subclavian artery revascularization, we do eval-
uate our patients either with CTA orMRA of the circle of theWillis
and the entire system and you can do that in most emergent cases
except the patients who come in with ruptured aneurysms. The
transection patients and dissection patients, they usually get that
type of evaluation. We are looking for a few things. We want to
make sure that they do not have a left vertebral that comes off the
arch. The one patient that did have some rest pain had a left
vertebral that came off the arch, and that is what provides the
outflow to the left arm and prevents most of these patients from
becoming symptomatic.
The second thing that we are looking at is, obviously, if they
had a coronary bypass graft, do you have a bypass graft based off
the left subclavian system as inflow? We do not want to create a
coronary problem for them.
In the two other situations to come up, about 0.4% of the
patients will have a left vertebral that does not form up with the
right vertebral to give you a true basilar, complete system, and they
will suffer a posterior stroke if you cover the left subclavian or what
we call dominant left vertebral artery situations.
Lastly, Peter Linn presented some anatomic variants where the
right vertebral will actually come off distal to the left subclavian
artery and so, technically, you could cover both vertebrals up if you
cover the left subclavian and then have a vertebral that is aberrant
and comes off distally, so each of those things have to be looked at.
You have to know that those are low incidence of anomalies that
exist and that you are going to address those.
Lastly, routine use of CSF drainage. While all of us have these
anecdotal issues where we put a CSF catheter in and got resolution
of spinal cord paraplegia, there is no data that shows it has been of
benefit in any level 1 instance. There are several of us that have
gotten together and have a proposal to get together to do this as a
nationwide evaluation of CSF drainage for thoracic endograft to
see if there is a benefit, what the risks are to it, and see if we can
improve it.
Lastly, Dr Coselli mentioned the stroke risk being higher than
what we’d like. That is true of all thoracic endograft procedures. It
is higher than our paraplegia risks in most studies. Ours was 11%,
but you are working further around in the arch and I would say that
raises it from the 6% to 8% that we see for a zone 3 or zone 4
deployment and raises it somewhat. You have to be very careful
with your technique and what you are doing.
